• 한국동물위생학회지
• /
• 제32권4호
• /
• pp.315-323
• /
• 2009

Foot-and-mouth disease (FMD) virus exists in seven serotypes and is known to be a highly contagious disease that is hard to eradicate from the world. The O, A, Asia1 and SAT2 serotypes commonly infected cattle, sheep and goats during 2007~2009 throughout the world. In particular, the outbreak of the Asia1 serotype in China appeared in all areas from 2005 and is still present. Surprisingly, in 2009, Taiwan reported the first outbreak of the type O serotype since 2001. Then type A appeared in China for the first time since the early 1960s. The virus shows a close relationship to the viruses from Southeast Asia suggesting one or more recent introductions into China in the OIE reports. Recently the subtype of A/Iran05 spread to nearby countries exhibiting genomic evolution. The use of molecular epidemiology is an important tool in understanding and consequently controlling the FMD virus. The phylogenetic analysis with VP1 gene was especially useful for molecular epidemiological studies and showed the same pattern which matches with serotype classification. This paper describes basic information about the disease, and the serotype-specific characteristics and evolution to perform molecular epidemiological analysis. Furthermore, we show the importance of the genetic evolution on the FMD serotypes in global surveillance and molecular epidemiology of FMD for outbreak investigation.

• 한국자원식물학회지
• /
• 제17권2호
• /
• pp.116-121
• /
• 2004

고려 인삼중 폐포와 4등급 이하를 유발시키는 90％이상이 적변삼이라고 불리는 인삼의 표피 색택이 붉은 삼이 그 원인이다. 이러한 적변삼은 미국삼보다는 고려 인삼에 서 다량 발견되는 바, 적변은 유전적 요인이 있다고 사료된다. 그러므로 이 연구의 목적은 RT-PCR을 이용하여 인삼적병에 내성을 가지는 유전자를 탐색하기 위하여 실시되었다. 고려인삼 3년근 1개체 중에서 적변이 발생된 부위와 건전 부위의 RNA를 추출하여 형성된 cDNA를 여러개의 random primer를 사용하여 PCR 증폭을 한 결과 정상 부위의 cDNA에서 발견되지 않는 band가 적변삼의 부위에서 발견되었다. 따라서 band가 형성된 부위의 유전자가 적변과 관련될 가능성이 있는 것으로 사료되고 이러한 유전자는 향후 염기서열을 분석하여 어떠한 유전자인지 판명을 하여야 하며 적변관련 유전자이면 선발마커로서 사용되고 또한 형질전환을 통한 적변내성 인삼계통을 육성할 수 있으며, 만약 적변과 관련이 없는 유전자로 판명된다면 더 많은 primer를 사용하여 적변관련 유전자를 탐색해야 할 것이다.

• 대한한방내과학회지
• /
• 제45권3호
• /
• pp.415-428
• /
• 2024

Objective and Methods: This study examined Cheng Guopeng (程國彭)'s understanding of Shanghan Disease (傷寒病) through <Yixue xinwu (醫學心悟)>, created tables based on this, and these tables were compared with <Shiyong zhongyi neike biaodian (實用中醫內科表典)>'s table on Six Meridian Pattern Identification (六經辨證). Results and Conclusion: 1. <Yixue xinwu> and <Shiyong zhongy neike biaodian> were mostly similar regarding the pathology and the Six Meridian Pattern Identification of Shanghan Disease. However, <Shiyong zhongyi neike biaodian> selected terms that encompass internal medical diseases rather than terms that refer only to infectious diseases. 2. About Taiyang meridian disease (太陽 經病), <Yixue xinwu> recognized the existence of Wen bing (溫病) and Re bing (熱病), but did not regard them as True Shanghan Disease (正傷寒), and differentially diagnosed them as Similar Shanghan Disease (類傷寒). 3. About Yangming meridian disease (陽明 經病), <Yixue xinwu> understood this as a meridian transmitted heat-syndrome in the interior (傳經 裏熱證), and created a new Radix Puerariae Decoction (葛根湯). This prescription has the same name as the <Shanghanlun (傷寒論)>, but it has a different drug composition and indications. 4. About three-In meridian disease (3陰 經病), <Yixue xinwu> always divided it into two categories: meridian transmitted heat-syndrome in the interior (傳經 裏熱證) and meridian stroked cold-syndrome in the interior (直中 裏寒證). However, <Shiyong zhongyi neike biaodian> described Taiin disease (太陰病) as Spleen-stomach deficiency cold-syndrome (脾胃虛寒證). This means that meridian transmitted heat-syndrome in the interior (傳經 裏熱證) does not exist among Taiin disease.

• 한국한의학연구원논문집
• /
• 제5권1호
• /
• pp.81-100
• /
• 1999

The result from the research on the disease classifications of the traditional medicine in China, Japan, Taiwan, and North Korea are followings: 1. It is remarkable that China has two different classifications. One is of the diseases named by western medicine and the other is of the syndromes compounded with parts, characters, and pathology of the diseases. The Traditional Chinese Medicine has 615 codes for diseases in 7 departments, and 1684 codes for syndromes. It seems that they have tried to match each disease named by the traditional chinese medicine to each one named by western medicine. But, they have left the diseases impossible to be equivalent to the ones in western medicine themselves and used the same codes of western medicine when the diseases are the same ones in western medicine. 2. In Taiwan, they try to connect the diseases named by the traditional medicine to the ones named by western medicine based on ICD-9. But, they did not attempt to classify the diseases of the traditional medicine by its own ways. The names of diseases in Taiwan medicine include both diseases and syndromes. It is limited to name syndromes by the traditional medicine. And, Taiwan medicine follows ICD in naming injuries. 3. Japan has not got the disease classification for the causes of death, but only the Japanese disease classification for the causes of death, a translation 'The international disease classification for the causes of death. Therefore, The diseases named by traditional medicines are excluded in the public medicine by some Japanese medicines which diagnose through the western medicine and treat by Wa Kang medicine. 4. I can't find out the data over the disease classification for the causes of death by traditional medicine in North Korea. Instead, I can refer to case histories in which differentiation of symptoms and signs and points about them by traditional medicine and the final diagnoses and report about examination by the western medicine has been recorded. In conclusion, It is a distinctive feature that they connect the diseases and the syndromes by the traditional medicine to the ones by the western medicine, and don't tell the diseases from the syndromes.

• 동의생리병리학회지
• /
• 제27권3호
• /
• pp.273-279
• /
• 2013

The objective of this study is to find out a reason why prescriptions have different effects on each patient who has same symptoms or same abdominal examinations and further more to classify the formulas more efficiently. In applying 's prescriptions, it is known that conventional ways such as treatment in accordance with symptoms or abdominal examinations have many advantages and problems reversely. To make up for the problems, additional references like strength of constitutional resistance and location of disease, degree of income and outgo are designed. And the notion in Oriental Medicine embracing aspects mentioned above corresponds to triple energizer. Triple energizer's exuberance-debilitation is able to draw an inference from some factors like density of skin interstices, elasticity of abdomen, appetite, digestive power. According to Exuberance-Debilitation of Triple Energizer, can be divided into five steps: weak(弱)-moderately weak(中弱)-neither weak nor strong(中)-moderately strong(中强)-strong(强). prescriptions would be dealt with those 5 steps, and it would be highly effective and consequently side effects could be reduced. On the basis of this classification method upon formula group, the prescriptions of can be applied more accurately by setting a direction through strength of constitutional resistance and location of disease and combining with existing references like symptoms, palpation and abdominal examinations.

• 한국의사학회지
• /
• 제31권1호
• /
• pp.71-87
• /
• 2018

This study investigated Hua Tuo's Shang-han theory, which precedes the period of Zhang Zhong Jing's Shang-han theory, and considers the relationship between the two approaches. Researchers compared terminology and language of Hua Tuo's Shang-han theory as published in Theory in Qian Jin Yao Fang and Wai Tai Mi Yao, with Zhang Zhong Jing's Shang-han theory. In Hua Tuo's theory, Shang-han involves pathogenic invasion of the body surface, where the pathogen transforms to 6 different stages, Pi (皮), Fu (膚), Ji (肌), Xiong (胸), Fu (腹), Wei (胃). Among these, the stage sof Pi (皮), Fu (膚), Ji (肌) can be considered as exterior syndrome (表證). Those that invade the lower chest can be considered as lower chest disease, and those that violate the abdomen or stomach can be considered as Interior heat excess syndrome (裏熱實證). Stomach heat excess syndrome (胃中實熱證) is the most severe and is similar to septicaemia or bubonic plague. Hua Tuo's treatment used three methods which are 汗 (perspiration), 吐 (emesis), 下 (purgation). In the case of Phlegm syndrome (痰?證), HuoTuo's theory was similar to Zhang Zhong Jing's Shang-han exterior syndrome (傷寒表證) and therefore used Zhuling-powder (猪?散). In the case of deficiency hot flush Syndrome (虛煩證) in Shang-han disease, HuoTuo uses ZhuYe-decoction (竹葉湯), of which the drug contents is the same as Zhang Zhong Jing's ZhuYeShiGao-decoction (竹葉石膏湯), which was used for the same condition.

• Tuberculosis and Respiratory Diseases
• /
• 제81권3호
• /
• pp.198-215
• /
• 2018

Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combination of long-acting ${\beta}_2-agonist$/long-acting muscarinic antagonists (LABA/LAMA) as the first-line treatment option in the majority of symptomatic patients with COPD. This review provides an indirect comparison of available LABA/LAMA fixed-dose combinations (FDCs) through discussion of important efficacy and safety data from the key literature, with the objective of providing physicians with a framework for informed decision-making. LABA/LAMA FDCs provided greater benefits compared with placebo and similar or greater benefits compared with tiotropium and salmeterol/fluticasone in improving lung function, dyspnea, health-related quality of life, reducing rescue medication use and preventing exacerbations, although with some variability in efficacy between individual FDCs; further, tolerability profiles were comparable among LABA/LAMA FDCs. However, there is a disparity in the amount of evidence generated for different LABA/LAMA FDCs. Thus, this review shows that all LABA/LAMA FDCs may not be the same and that care should be taken when extrapolating individual treatment outcomes to the entire drug class. It is important that physicians consider the efficacy gradient that exists among LABA/LAMA FDCs, and factors such as inhaler devices and potential biomarkers, when choosing the optimal bronchodilator treatment for long-term management of patients with COPD.

• 디지털융복합연구
• /
• 제13권11호
• /
• pp.217-230
• /
• 2015

본 연구는 의료이용 동기(경증, 중증, 만성질환관리, 미용)에 따른 의료기관 선택기준의 차이를 알아보기 위해 시행되었다. 의료이용 동기에 따른 병원선택요인의 중요도는 감기와 같은 경증질환의 경우 진료능력, 친절, 신속, 접근성 순이었으며 암과 같은 중증질환의 경우와 미용의 경우는 진료능력, 시설, 평판, 진료비 순이었고 합병증 없는 고혈압관리와 같은 만성질환 관리의 경우는 진료능력, 시설, 친절, 진료비 순이었다. 의료이용 동기와 관계없이 진료능력은 의료기관 선택에 가장 중요한 요인이었으며 중증질환의 경우 접근성을 제외한 모든 요인에 대한 중요도가 높았다. 결론적으로 의료이용자들은 의료이용 동기, 질병의 심각성과 위급성 등을 복합적으로 고려하여 의료기관을 선택하며 같은 경우라도 인구학적 특성 및 정보탐색행태에 따라서 달라진다는 점을 알 수 있었다. 이에 의료기관의 경쟁우의를 확보하기 위해 수동적인 태도, 타 의료기관의 무조건적인 모방이 아니라 의료기관 선택요인에 대한 이해를 바탕으로 타 의료기관과 차별화하는 전략을 세워야 할 것이다.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제18권3호
• /
• pp.443-447
• /
• 1996

Angiolymphoid hyperplasia with eosinophilia(ALHE) is an uncommon, benign vascular proliferation with the background of a stroma which is heavily infiltrated by lymphocytes and eosinophils and includes lymphatic follicles with prominent germinal centers. ALHE primarily involves the skin and subcutis in head and neck as various forms of nodules. There has been considerable controversy about the relationship between ALHE and Kimura's disease. Kimura's disease, originally reported by Kimura et el., is an unusual granulation with proliferation of lymphoid tissue. Wells and Whimster published the first report describing a condition that resembled Kimura's disease and designated it as ALHE. For a time being two lesions are thought to be same lesion, but recently they are considered as two different entities, histopathologically. The cause of this disease remains unknown, and physicians have used a variety of treatment modalities including cryosurgery, steriod therapy, electrodesiccation, curettage, radiotherapy, laser therapy and surgical excision. But any treatment modality leaves problem of recurrence because the lesion is not well encapsulated. Being poorly encapsulated, the lesion's remnants are apt to be left and this markes some problems : recurrence and possible adjacent organ injury. In this case we misdiagnosed the lesion as well encapsulated benign mass. We performed excisional biopsy and experienced prolonged operation time and unwanted mentalis muscle injury. We think that the importance of poor encapsulation of ALHE should be stressed. So we report our experience with literature review.

• Journal of Chest Surgery
• /
• 제33권1호
• /
• pp.73-78
• /
• 2000

Background: this study was designed to estimate whether specific risk factors could increase the postoperative complication rate of pneumonectomy for chronic complicated inf-lammatory lung disease. Material and Method: Eighty-five patients underwent pneumon-ectomy for chronic complicated inflammatory lung disease(tuberculosis, 67 ; bronchiecasis 11; aspergio- losis, 4; others, 3) between January 1991 and August 1998. We performed a univariated statistical analysis to identify preoperative and intraoperative risk factors associated with postoperative complications, Result: There was no operative mortality. There were a total of 18 postoperative complications(22.2%) Bronchopleural fistula(BPF) and empyema occurred in 5(5.9%) and 2(2.4%) respectively. General complication rate was significantly higher in patients with right-sided pneumonectomy(p=.029) extrapleural pneu-monectomy(p=.009) and intraoperative pleural spillage due to cavity or lesion perforation (p=.004). The prevalence of BPF and empyema was higher in patients with right sided pneumonectomy(p=.007) extrapleural pneumonectomy(p=.015) and intraoperative pl- eural spillage due to cavity or lesion perforation(p=.003) which is as the same results as gen-eral complication rate. Conclusion: The postoperative complication rate of pneumone-ctomy for chronic complicated lung disease is accptably low. But it is increase in patients with right sided pneumonectomy extrapleural pneumonectomy and intraoperative pleural spillage due to cavity or lesion perforation. therefore more careful and meticulous intra-operatve management are needed in right sided extrapleural pneumonectomy without intra- pleural spillage.